Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fidu...
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors...
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
When Anthem Blue Cross Blue Shield said it will no longer pay for anesthesia care if the surgery or procedure exceeds an arbitrary time limit, parent company Elevance Health Inc ELV faced backlash ...
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated sec...
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others vi...
What's Behind The 15% Fall For Elevance Health Stock?
Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnin...
Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer
Elevance Health's Q3 2024 results were disappointing with a significant increase in the benefit expense ratio and lowered earnings expectations for the full year. I take a close look at ELV's expos...
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Elevance Health's Q3 earnings report led to a 14% stock price drop due to increased benefit expense ratio and declining EPS. The health insurance industry faces challenges, particularly in Medicare...
Elevance Health's Q3 Earnings Miss Due to Medicaid Redeterminations
ELV's third-quarter earnings are hurt by declining membership in Medicaid and Medicare, partially offset by improved product revenues.
Elevance Health (ELV) Q3 Earnings Lag Estimates
Elevance Health (ELV) came out with quarterly earnings of $8.37 per share, missing the Zacks Consensus Estimate of $9.70 per share. This compares to earnings of $8.99 per share a year ago.
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elevance's Pre-Q3 Earnings Analysis: Smart Buy Now or Caution Ahead?
ELV's third-quarter results are likely to reflect growing operating income from the Carelon business.
Gear Up for Elevance Health (ELV) Q3 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared dur...
Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Elevance is a high-quality compounder with consistent EPS growth, trading at a significant discount to peers like UnitedHealth, presenting an attractive entry point. Despite recent stock dips due t...
Here's Why You Should Add Elevance Health Stock to Your Portfolio
ELV benefits from an increase in employer group fee-based memberships, partially offsetting the impact of Medicaid memberships.
Elevance Health: Healthcare Services Segment Is Gaining Traction
Elevance Health's health insurance segment is well diversified, with a meaningful exposure to commercial services-only memberships and Medicaid. ELV has been doing a great job handling the current ...
Related Companies